Safety of Acupuncture Versus Primary Medical Care With Prescription Drug Therapy Among Medicare Fee-for-Service Beneficiaries With Low Back Pain: A Retrospective Observational Study

Study Design: Retrospective, observational study. Objective: To compare adverse outcomes among Medicare fee-for-service (FFS) beneficiaries with LBP receiving acupuncture versus primary care with prescription drug therapy (PDT). Summary of Background Data: In 2020, the Centers for Medicare and Medicaid Services initiated coverage of acupuncture for chronic low back pain (LBP). Materials and Methods: We analyzed 2020 to 2023 Medicare claims data for noninstitutionalized Medicare FFS beneficiaries enrolled under Parts A, B, and D for ≥365 days prior to and 180 days after the initial visit. We compared rates of outpatient adverse events between two mutually exclusive cohorts of patients with episodes of LBP, assembled according to initial treatment received. The acupuncture (ACU) exposure group was defined by an initial visit for LBP with an acupuncture procedure code (97810, 97811, 97813, 97814, 20560, 20561). The prescription drug therapy (PDT) group was defined by an initial visit for LBP with a primary care physician and an analgesic prescription filled within seven days, without acupuncture. Specifically, six-month outcomes included outpatient adverse drug events (ADEs) and pneumothorax. Inverse propensity weighting balanced beneficiary characteristics. Adjusted logistic and Poisson regression models with robust SEs compared outcomes between groups. Results: The ACU group contained 13,113 beneficiaries and the PDT group 366,817. Pneumothorax risk (RR=0.259, 95% CI: 0.118–0.556, P <0.001) and cumulative adverse event risk (RR=0.346, 95% CI: 0.191–0.628, P <0.001) were significantly lower in the ACU group. Adjusted odds of any adverse event trended lower in the ACU group (OR=0.558, 95% CI: 0.282–1.106, P =0.094), as did ADE risk (RR=0.540, 95% CI: 0.222–1.312, P =0.174). Conclusions: Among Medicare beneficiaries with LBP, the risk of adverse outcomes was lower with acupuncture than with primary care and PDT. However, differences may reflect referral patterns and patient selection rather than treatment effects.

Authors

Institutions

Publication Details

Journal
Spine Open
Published
2026-11-17
DOI
https://doi.org/10.1097/bn9.0000000000000166
Primary Topic
Acupuncture Treatment Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Safety of Acupuncture Versus Primary Medical Care With Prescription Drug Therapy Among Medicare Fee-for-Service Beneficiaries With Low Back Pain: A Retrospective Observational Study

Louis A. Kazal, Todd A. MacKenzie, Sivarama Prasad Vinjamury, Leah M. Grout et al.
2 links
Spine Open
Acupuncture Treatment Research Studies
article

Safety of Acupuncture Versus Primary Medical Care With Prescription Drug Therapy Among Medicare Fee-for-Service Beneficiaries With Low Back Pain: A Retrospective Observational Study

Louis A. Kazal, Todd A. MacKenzie, Sivarama Prasad Vinjamury, Leah M. Grout, James M. Whedon
article en

Abstract

Study Design: Retrospective, observational study. Objective: To compare adverse outcomes among Medicare fee-for-service (FFS) beneficiaries with LBP receiving acupuncture versus primary care with prescription drug therapy (PDT). Summary of Background Data: In 2020, the Centers for Medicare and Medicaid Services initiated coverage of acupuncture for chronic low back pain (LBP). Materials and Methods: We analyzed 2020 to 2023 Medicare claims data for noninstitutionalized Medicare FFS beneficiaries enrolled under Parts A, B, and D for ≥365 days prior to and 180 days after the initial visit. We compared rates of outpatient adverse events between two mutually exclusive cohorts of patients with episodes of LBP, assembled according to initial treatment received. The acupuncture (ACU) exposure group was defined by an initial visit for LBP with an acupuncture procedure code (97810, 97811, 97813, 97814, 20560, 20561). The prescription drug therapy (PDT) group was defined by an initial visit for LBP with a primary care physician and an analgesic prescription filled within seven days, without acupuncture. Specifically, six-month outcomes included outpatient adverse drug events (ADEs) and pneumothorax. Inverse propensity weighting balanced beneficiary characteristics. Adjusted logistic and Poisson regression models with robust SEs compared outcomes between groups. Results: The ACU group contained 13,113 beneficiaries and the PDT group 366,817. Pneumothorax risk (RR=0.259, 95% CI: 0.118–0.556, P <0.001) and cumulative adverse event risk (RR=0.346, 95% CI: 0.191–0.628, P <0.001) were significantly lower in the ACU group. Adjusted odds of any adverse event trended lower in the ACU group (OR=0.558, 95% CI: 0.282–1.106, P =0.094), as did ADE risk (RR=0.540, 95% CI: 0.222–1.312, P =0.174). Conclusions: Among Medicare beneficiaries with LBP, the risk of adverse outcomes was lower with acupuncture than with primary care and PDT. However, differences may reflect referral patterns and patient selection rather than treatment effects.

Spine OpenVol. 2(4)
Dartmouth College (US), Southern California University of Health Sciences (US)
Good health and well-being
Acupuncture Treatment Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon